These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11919069)

  • 1. Papanicolaou test use among reproductive-age women at high risk for cervical cancer: analyses of the 1995 National Survey of Family Growth.
    Hewitt M; Devesa S; Breen N
    Am J Public Health; 2002 Apr; 92(4):666-9. PubMed ID: 11919069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Race-specific results of Papanicolaou testing and the rate of cervical neoplasia in the National Breast and Cervical Cancer Early Detection Program, 1991-1998 (United States).
    Benard VB; Lee NC; Piper M; Richardson L
    Cancer Causes Control; 2001 Jan; 12(1):61-8. PubMed ID: 11227926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cervical cancer screening: who is not screened and why?
    Harlan LC; Bernstein AB; Kessler LG
    Am J Public Health; 1991 Jul; 81(7):885-90. PubMed ID: 2053665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perceived discrimination is associated with reduced breast and cervical cancer screening: the Study of Women's Health Across the Nation (SWAN).
    Jacobs EA; Rathouz PJ; Karavolos K; Everson-Rose SA; Janssen I; Kravitz HM; Lewis TT; Powell LH
    J Womens Health (Larchmt); 2014 Feb; 23(2):138-45. PubMed ID: 24261647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Family history of cancer predicts Papanicolaou screening behavior for African American and white women.
    Williams KP; Reiter P; Mabiso A; Maurer J; Paskett E
    Cancer; 2009 Jan; 115(1):179-89. PubMed ID: 19025974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to cervical cancer screening guidelines for U.S. women aged 25-64: data from the 2005 Health Information National Trends Survey (HINTS).
    Nelson W; Moser RP; Gaffey A; Waldron W
    J Womens Health (Larchmt); 2009 Nov; 18(11):1759-68. PubMed ID: 19951209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Attendance rate in the Polish Cervical Cancer Screening Program in the years 2007-2009].
    Spaczyński M; Karowicz-Bilinska A; Rokita W; Molińska-Glura M; Januszek-Michalecka L; Seroczyński P; Uchlik J; Nowak-Markwitz E
    Ginekol Pol; 2010 Sep; 81(9):655-63. PubMed ID: 20973201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Papanicolaou testing among women in the southern United States.
    Peterson NB; Murff HJ; Cui Y; Hargreaves M; Fowke JH
    J Womens Health (Larchmt); 2008; 17(6):939-46. PubMed ID: 18582173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in cervical cancer screening and follow-up for black and white women in the United States.
    Ford S; Tarraf W; Williams KP; Roman LA; Leach R
    Gynecol Oncol; 2021 Feb; 160(2):369-374. PubMed ID: 33323276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast and cervical cancer screening: sociodemographic predictors among White, Black, and Hispanic women.
    Selvin E; Brett KM
    Am J Public Health; 2003 Apr; 93(4):618-23. PubMed ID: 12660207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barriers and missed opportunities in breast and cervical cancer screening among women aged 50 and over, New York City, 2002.
    Nash D; Chan C; Horowitz D; Vlahov D
    J Womens Health (Larchmt); 2007; 16(1):46-56. PubMed ID: 17324096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Personal influencing factors associated with pap smear testing and cervical cancer.
    Ackerson K; Pohl J; Low LK
    Policy Polit Nurs Pract; 2008 Feb; 9(1):50-60. PubMed ID: 18492942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and sociocultural factors associated with cervical cancer screening among HIV-infected African American women in Alabama.
    Williams M; Moneyham L; Kempf MC; Chamot E; Scarinci I
    AIDS Patient Care STDS; 2015 Jan; 29(1):13-9. PubMed ID: 25514125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast and cervical cancer screening for Puerto Ricans, African Americans, and non-Hispanic whites attending inner-city family practice centers.
    Finney MF; Tumiel-Berhalter LM; Fox C; Jaén CR
    Ethn Dis; 2006; 16(4):994-1000. PubMed ID: 17061758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective lay health worker outreach and media-based education for promoting cervical cancer screening among Vietnamese American women.
    Mock J; McPhee SJ; Nguyen T; Wong C; Doan H; Lai KQ; Nguyen KH; Nguyen TT; Bui-Tong N
    Am J Public Health; 2007 Sep; 97(9):1693-700. PubMed ID: 17329652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sociodemographic predictors of adherence to annual cervical cancer screening in minority women.
    Jennings-Dozier K; Lawrence D
    Cancer Nurs; 2000 Oct; 23(5):350-6; quiz 357-8. PubMed ID: 11037955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical cancer screening among U.S. women: analyses of the 2000 National Health Interview Survey.
    Hewitt M; Devesa SS; Breen N
    Prev Med; 2004 Aug; 39(2):270-8. PubMed ID: 15226035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for Cervical Cancer and Sexually Transmitted Diseases Among HIV-Infected Women.
    Frazier EL; Sutton MY; Tie Y; McNaghten AD; Blair JM; Skarbinski J
    J Womens Health (Larchmt); 2016 Feb; 25(2):124-32. PubMed ID: 26447835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physician recommendation for papanicolaou testing among U.S. women, 2000.
    Coughlin SS; Breslau ES; Thompson T; Benard VB
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1143-8. PubMed ID: 15894664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pap screening goals and perceptions of pain among black, Latina, and Arab women: steps toward breaking down psychological barriers.
    Gauss JW; Mabiso A; Williams KP
    J Cancer Educ; 2013 Jun; 28(2):367-74. PubMed ID: 23288606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.